This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice.
A new preprint design is coming!
We have improved readability, clarity, accessibility, and opportunities for engagement.
Research
Rui Chen
Third Affiliated Hospital of Guangzhou Medical College
Corresponding Author
License:
This work is licensed under a CC BY 4.0 License. Read Full License
Background: Endometriosis (EM) affects 10% of women in reproductive age and alters fertility. Its management is still debated notably the timing of surgery and ART in infertility. Kallistatin (KS) is an endogenous protein that regulates differential signaling pathways and biological functions. However, the function and the underlying molecular mechanism in endometriosis and its correlation with IVF outcome have not been determined. The purpose of this study was to evaluate KS concentrations in follicular fluid of women with EM and controls women without EM who underwent IVF with embryo transfer (IVF–ET).
Methods: Follicular fluid KS concentrations from 40 patients with EM and 40 non-EM patients were measured by ELISA.
Results: Compared with the non-EM patients, patients with EM had lower KS levels in follicular fluid (281.67±104.60 pg/ml vs. 490.70 ±216.33pg/ml). The rates of fertilization(61.64±22.42% vs. 71.00±24.39%) , available embryo (45.96±19.83% vs.50.61±26.26%) and top-quality embryo(12.71±21.01% vs.16.04±16.87%) were significantly lower in the EM group than in the control group. The KS concentrations in the follicular fluid of women who conceived consequent to the treatment were significantly higher than those from women who did not in the combined EM and control groups.
Conclusions:
The present results indicate that the KS concentration in follicular fluid could be used as a predictor for IVF–ET outcomes. This may contribute to the pathologic mechanism responsible for the poor outcome of IVF in patients with EM.
Keywords
Endometriosis; Kallistatin; follicular fluid; IVF outcome
Figure 1
This is a list of supplementary files associated with this preprint. Click to download.
Loading...
Badges
Prescreen
This manuscript passed our Prescreen assessment
Complete author information
Appropriate declaration statements
Potential risks to human health
Prescreen
History
CURRENT STATUS: Posted
View the published article at Gynecological Endocrinology.
Version 1
Posted 09 Jan, 2021
No community comments so far
Metrics
Comments: 0
PDF Downloads: ...
HTML Views: ...
Subject Areas
Endocrinology & Metabolism
Learn more about our company.
A new preprint design is coming!
We have improved readability, clarity, accessibility, and opportunities for engagement.
This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice.
Research
Rui Chen
Third Affiliated Hospital of Guangzhou Medical College
Corresponding Author
Badges
Prescreen
This manuscript passed our Prescreen assessment
Complete author information
Appropriate declaration statements
Potential risks to human health
Prescreen
History
CURRENT STATUS: Posted
View the published article at Gynecological Endocrinology.
Version 1
Posted 09 Jan, 2021
No community comments so far
Metrics
Comments: 0
PDF Downloads: ...
HTML Views: ...
Subject Areas
Endocrinology & Metabolism
License:
This work is licensed under a CC BY 4.0 License. Read Full License
View the published article at Gynecological Endocrinology.
Background: Endometriosis (EM) affects 10% of women in reproductive age and alters fertility. Its management is still debated notably the timing of surgery and ART in infertility. Kallistatin (KS) is an endogenous protein that regulates differential signaling pathways and biological functions. However, the function and the underlying molecular mechanism in endometriosis and its correlation with IVF outcome have not been determined. The purpose of this study was to evaluate KS concentrations in follicular fluid of women with EM and controls women without EM who underwent IVF with embryo transfer (IVF–ET).
Methods: Follicular fluid KS concentrations from 40 patients with EM and 40 non-EM patients were measured by ELISA.
Results: Compared with the non-EM patients, patients with EM had lower KS levels in follicular fluid (281.67±104.60 pg/ml vs. 490.70 ±216.33pg/ml). The rates of fertilization(61.64±22.42% vs. 71.00±24.39%) , available embryo (45.96±19.83% vs.50.61±26.26%) and top-quality embryo(12.71±21.01% vs.16.04±16.87%) were significantly lower in the EM group than in the control group. The KS concentrations in the follicular fluid of women who conceived consequent to the treatment were significantly higher than those from women who did not in the combined EM and control groups.
Conclusions:
The present results indicate that the KS concentration in follicular fluid could be used as a predictor for IVF–ET outcomes. This may contribute to the pathologic mechanism responsible for the poor outcome of IVF in patients with EM.
Figure 1
This is a list of supplementary files associated with this preprint. Click to download.
Loading...